{
    "nctId": "NCT00793390",
    "briefTitle": "Case-Control Study of Inflammatory Breast Cancer in North Africa",
    "officialTitle": "A Case-Control Study of Inflammatory Breast Cancer in North Africa",
    "overallStatus": "COMPLETED",
    "conditions": "Diabetes",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 815,
    "primaryOutcomeMeasure": "breast cancer",
    "eligibilityCriteria": "* The case-control study will be restricted to women at least 18 years of age. IBC cases will be defined as having any clinical signs of redness, and either edema or peau d' orange characteristic of IBC or evidence of tumor emboli in the dermal lymphatics (at the center in Rabat).\n\nCases with extensive ulceration of the breast or with breast carcinoma 'en cuirasse' will be excluded from the study, even if erythema is present.\n\nWomen with a previous diagnosis of breast cancer will be excluded.\n\nAll cancers will be pathologically confirmed with evidence of tumor in either the breast parenchyma or dermal lymphatics based on the diagnostic biopsy.\n\nCases newly diagnosed and/or treated at study hospitals will be included.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}